Example of Ophthalmology and Therapy format
Recent searches

Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format Example of Ophthalmology and Therapy format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Ophthalmology and Therapy — Template for authors

Publisher: Springer
Categories Rank Trend in last 3 yrs
Ophthalmology #29 of 116 down down by 25 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 213 Published Papers | 775 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 20/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

Springer

Quality:  
High
CiteRatio: 4.4
SJR: 1.196
SNIP: 1.258
open access Open Access
recommended Recommended

BMJ Publishing Group

Quality:  
High
CiteRatio: 7.3
SJR: 2.016
SNIP: 2.055
open access Open Access
recommended Recommended

Elsevier

Quality:  
High
CiteRatio: 7.1
SJR: 2.704
SNIP: 2.303
open access Open Access
recommended Recommended

Elsevier

Quality:  
High
CiteRatio: 14.9
SJR: 5.028
SNIP: 4.169

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

3.6

24% from 2019

CiteRatio for Ophthalmology and Therapy from 2016 - 2020
Year Value
2020 3.6
2019 2.9
2017 8.7
2016 5.3
graph view Graph view
table view Table view

1.189

52% from 2019

SJR for Ophthalmology and Therapy from 2016 - 2020
Year Value
2020 1.189
2019 0.78
2017 0.695
2016 0.664
graph view Graph view
table view Table view

1.566

47% from 2019

SNIP for Ophthalmology and Therapy from 2016 - 2020
Year Value
2020 1.566
2019 1.065
2017 0.79
2016 1.023
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has increased by 24% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has increased by 52% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 47% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Ophthalmology and Therapy

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Springer

Ophthalmology and Therapy

Approved by publishing and review experts on SciSpace, this template is built as per for Ophthalmology and Therapy formatting guidelines as mentioned in Springer author instructions. The current version was created on 20 Jun 2020 and has been used by 513 authors to write and format their manuscripts to this journal.

Eye surgery

i
Last updated on
20 Jun 2020
i
ISSN
1606-8610
i
Open Access
No
i
Sherpa RoMEO Archiving Policy
White faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
SPBASIC
i
Citation Type
Author Year
(Blonder et al, 1982)
i
Bibliography Example
Beenakker CWJ (2006) Specular andreev reflection in graphene. Phys Rev Lett 97(6):067,007, URL 10.1103/PhysRevLett.97.067007

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1007/S40123-013-0020-5
Intraocular Pressure Effects of Common Topical Steroids for Post-Cataract Inflammation: Are They All the Same?
Uwe Pleyer1, Paul G. Ursell, Paolo Rama

Abstract:

The efficacy of topical corticosteroids as ocular anti-inflammatory agents following cataract surgery is well-documented. They also help to prevent a number of complications associated with post-operative ocular inflammation, including corneal edema and cystoid macular edema. However, topical corticosteroids are associated wi... The efficacy of topical corticosteroids as ocular anti-inflammatory agents following cataract surgery is well-documented. They also help to prevent a number of complications associated with post-operative ocular inflammation, including corneal edema and cystoid macular edema. However, topical corticosteroids are associated with side effects, such as increased intraocular pressure (IOP). Indeed, corticosteroid-induced ocular hypertension and the potential for steroid-induced glaucoma remain the leading drawbacks of topical corticosteroid therapy. Some individuals are known to experience a high degree of IOP elevation with low doses or short durations of treatment with topical corticosteroids. Careful monitoring of IOP in such individuals is essential. Few randomized, controlled studies are available on the comparative safety and efficacy of common topical corticosteroids in the treatment of post-operative ocular inflammation. Furthermore, the lack of consistent reporting criteria for clinically significant IOP increases across clinical studies makes meaningful comparisons among corticosteroids difficult. This review aims to examine data from available published studies, including studies in steroid responders, to determine whether topical corticosteroids are the same in terms of their effect on IOP. Early generation corticosteroids, such as dexamethasone and prednisolone, are more likely to result in clinically significant increases in IOP. Newer corticosteroids, such as rimexolone and the retro-metabolically designed corticosteroid, loteprednol etabonate, offer similar anti-inflammatory efficacy to older corticosteroids with less effect on IOP. However, randomized controlled trials of newer corticosteroids are needed. The proportion of patients exhibiting an increase of ≥10 mmHg IOP in clinical studies has emerged as the most clinically relevant parameter for ophthalmologists to consider when deciding on which topical corticosteroid to use. read more read less

Topics:

Topical Corticosteroid Therapy (62%)62% related to the paper, Intraocular pressure (53%)53% related to the paper, Ocular hypertension (51%)51% related to the paper
View PDF
120 Citations
open accessOpen access Journal Article DOI: 10.1007/S40123-020-00282-6
Face Mask-Associated Ocular Irritation and Dryness.
Majid Moshirfar1, Majid Moshirfar2, William B. West2, Douglas P. Marx2

Abstract:

During the current coronavirus disease 2019 (COVID-19) epidemic, the concern for reducing disease transmission has led to a worldwide increase in face mask utilization. During this period, we have observed a corresponding increase in ocular irritation and dryness among regular mask users. This finding has not been previously ... During the current coronavirus disease 2019 (COVID-19) epidemic, the concern for reducing disease transmission has led to a worldwide increase in face mask utilization. During this period, we have observed a corresponding increase in ocular irritation and dryness among regular mask users. This finding has not been previously described in the literature but has important implications on eye health and infection prevention, as mask use is likely to continue for the foreseeable future. read more read less
View PDF
105 Citations
open accessOpen access Journal Article DOI: 10.1007/S40123-018-0131-0
Systematic Literature Review of Clinical and Economic Outcomes of Micro-Invasive Glaucoma Surgery (MIGS) in Primary Open-Angle Glaucoma
Pavi Agrawal1, Steven E. Bradshaw

Abstract:

Primary open-angle glaucoma is estimated to affect 3% of the population aged 40–80 years. Trabeculectomy is considered the gold standard in surgical management of glaucoma; however, it is a technically complex procedure that may result in a range of adverse outcomes. Device-augmented, minimally invasive procedures (micro-inva... Primary open-angle glaucoma is estimated to affect 3% of the population aged 40–80 years. Trabeculectomy is considered the gold standard in surgical management of glaucoma; however, it is a technically complex procedure that may result in a range of adverse outcomes. Device-augmented, minimally invasive procedures (micro-invasive glaucoma surgeries, MIGS) have been developed aiming for safer and less invasive intraocular pressure (IOP) reduction compared with traditional surgery. This paper presents results from a systematic literature review conducted in accordance with National Institute for Health and Care Excellence requirements for the Medical Technology Evaluation Programme via multiple databases from 2005 to 2016. For clinical outcomes, randomized clinical trials (RCTs) comparing MIGS with trabeculectomy or other therapies, observational studies, and other non-RCTs were included. Clinical outcomes reviewed were the change from baseline in mean IOP levels and change in topical glaucoma medication. Safety was assessed by reported harm and adverse events. For economic evidence, trials on cost-effectiveness, cost-utility, cost-benefit, cost-consequences, cost-minimization, cost of illness, and specific procedure costs were included. Risk of bias was assessed for clinical studies using the Cochrane Risk of Bias tool. A total of nine RCTs (seven iStents®, one Hydrus®, and one CyPass®), seven non-RCTs (three iStent®, three CyPass®, and one Hydrus®), and 23 economic studies were analyzed. While various forms of trabeculectomy can achieve postoperative IOP of between 11.0 and 13.0 mmHg, MIGS devices described in this review were typically associated with higher postoperative IOP levels. In addition, MIGS devices may result in increased hypotony rates or bleb needling in subconjunctival placed devices, requiring additional medical resources to manage. There is limited available evidence on the cost-effectiveness of MIGS and therefore it remains unclear whether the cost of using MIGS is outweighed by cost savings through decreased medication and need for further interventions. Larger randomized trials and real-world observational studies are needed for MIGS devices to better assess clinical and economic effectiveness. Given the shortage of published data and increasing use of such procedures, living systematic reviews may help to provide ongoing and timely evidence-based direction for clinicians and decision makers. This review highlights the current unmet need for treatments that are easy to implement and reduce long-term IOP levels without increasing postoperative aftercare and cost. Santen GmbH, Germany. read more read less

Topics:

Glaucoma medication (56%)56% related to the paper, Glaucoma surgery (54%)54% related to the paper, Systematic review (53%)53% related to the paper, Randomized controlled trial (52%)52% related to the paper, Population (51%)51% related to the paper
View PDF
90 Citations
open accessOpen access Journal Article DOI: 10.1007/S40123-013-0019-Y
Management of Vernal Keratoconjunctivitis
Andrea Leonardi1

Abstract:

Vernal keratoconjunctivitis (VKC) is a relatively rare, chronic form of ocular allergy that can potentially cause severe visual complications. Affecting mainly children and young adults, it is an IgE- and T cell-mediated disease, leading to a chronic inflammation in which eosinophil, lymphocyte and structural cell activation ... Vernal keratoconjunctivitis (VKC) is a relatively rare, chronic form of ocular allergy that can potentially cause severe visual complications. Affecting mainly children and young adults, it is an IgE- and T cell-mediated disease, leading to a chronic inflammation in which eosinophil, lymphocyte and structural cell activation are involved. Treatment of VKC requires a multiple approach that includes conservative measures and pharmacologic treatment. Patients and parents should be made aware of the long duration of disease, its chronic evolution and possible complications. Treatment should be based on the duration and frequency of symptoms and the severity of corneal involvement. Mast cell stabilizers and antihistamines have been proven to be effective for the treatment of mild to moderate forms of VKC. In the most severe cases, topical steroids can be used as rescue medication to reduce conjunctival and corneal inflammation. Immunomodulators that have been investigated for VKC treatment include topical ocular preparations of cyclosporine A and tacrolimus. Topical cyclosporine A has been proven to be effective in the long-term treatment of VKC, significantly improving signs and symptoms without significant side effects. read more read less

Topics:

Vernal keratoconjunctivitis (59%)59% related to the paper, Corneal inflammation (57%)57% related to the paper, Cell activation (52%)52% related to the paper
View PDF
82 Citations
open accessOpen access Journal Article DOI: 10.1007/S40123-017-0099-1
Keratoconus Treatment Algorithm

Abstract:

Keratoconus management has significantly changed over the last two decades. The advent of new interventions such as cornea cross-linking, intrastromal corneal ring segments, and combined treatments provide corneal clinicians a variety of treatment options for the visual rehabilitation of keratoconus patients. This review summ... Keratoconus management has significantly changed over the last two decades. The advent of new interventions such as cornea cross-linking, intrastromal corneal ring segments, and combined treatments provide corneal clinicians a variety of treatment options for the visual rehabilitation of keratoconus patients. This review summarizes current evidence for these treatments and highlights their place in keratoconus management while new promising emerging therapies are being investigated. read more read less

Topics:

Keratoconus (57%)57% related to the paper
View PDF
81 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Ophthalmology and Therapy.

It automatically formats your research paper to Springer formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Ophthalmology and Therapy format uses SPBASIC citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Ophthalmology and Therapy in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Ophthalmology and Therapy guidelines and auto format it.

2. Do you follow the Ophthalmology and Therapy guidelines?

Yes, the template is compliant with the Ophthalmology and Therapy guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Ophthalmology and Therapy?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Ophthalmology and Therapy citation style.

4. Can I use the Ophthalmology and Therapy templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Ophthalmology and Therapy.

5. Can I use a manuscript in Ophthalmology and Therapy that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Ophthalmology and Therapy that you can download at the end.

6. How long does it usually take you to format my papers in Ophthalmology and Therapy?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Ophthalmology and Therapy.

7. Where can I find the template for the Ophthalmology and Therapy?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Ophthalmology and Therapy's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Ophthalmology and Therapy's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Ophthalmology and Therapy an online tool or is there a desktop version?

SciSpace's Ophthalmology and Therapy is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Ophthalmology and Therapy?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Ophthalmology and Therapy?”

11. What is the output that I would get after using Ophthalmology and Therapy?

After writing your paper autoformatting in Ophthalmology and Therapy, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Ophthalmology and Therapy's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Ophthalmology and Therapy?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Ophthalmology and Therapy. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Ophthalmology and Therapy?

The 5 most common citation types in order of usage for Ophthalmology and Therapy are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Ophthalmology and Therapy?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Ophthalmology and Therapy's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Ophthalmology and Therapy in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Ophthalmology and Therapy Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Ophthalmology and Therapy formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template